CLASS B COMMON STOCK PURCHASE WARRANT PROTAGONIST THERAPEUTICS, INC.Protagonist Therapeutics, Inc • August 7th, 2018 • Pharmaceutical preparations • Delaware
THIS CLASS B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August , 2018 (the “Initial Exercise Date”) and on or prior to the Termination Date but not thereafter, to subscribe for and purchase from Protagonist Therapeutics, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder), the “Warrant Shares”) of the Company’s common stock, par value $0.00001 per share (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 7th, 2018 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • Delaware
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of August [ ], 2018 by and among Protagonist Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”) and the several purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).
